Sublethal concentrations of 17-AAG suppress homologous recombination DNA repair and enhance sensitivity to carboplatin and olaparib in HR proficient ovarian cancer cells-Reference-Cited by-同舟云学术

Sublethal concentrations of 17-AAG suppress homologous recombination DNA repair and enhance sensitivity to carboplatin and olaparib in HR proficient ovarian cancer cells

Published:2014-04-30 Issue:9 Volume:5 Page:2678-2687
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Choi Young Eun¹,Battelli Chiara²,Watson Jacqueline¹,Liu Joyce³,Curtis Jennifer³,Morse Alexander N.⁴,Matulonis Ursula A.³,Chowdhury Dipanjan¹,Konstantinopoulos Panagiotis A.¹³

Affiliation:

1. Department of Radiation Oncology, Dana Farber Cancer Institute, Harvard Medical School

2. Maine Center for Cancer Medicine, Scarborough, Maine

3. Department of Medical Oncology, Medical Gynecologic Oncology Program, Dana Farber Cancer Institute, Harvard Medical School

4. New York University Global Institute of Public Health

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting HSP90 in Gynecologic Cancer: Molecular Mechanisms and Therapeutic Approaches;Cell Biochemistry and Biophysics;2024-09-09

2. Homologous recombination proficient subtypes of high-grade serous ovarian cancer: treatment options for a poor prognosis group;Frontiers in Oncology;2024-06-04

3. Combination therapy involving HSP90 inhibitors for combating cancer: an overview of clinical and preclinical progress;Archives of Pharmacal Research;2024-04-17

4. LCK facilitates DNA damage repair by stabilizing RAD51 and BRCA1 in the nucleus of chemoresistant ovarian cancer;Journal of Ovarian Research;2023-06-27

5. Smart Nanofiber Mesh with Locally Sustained Drug Release Enabled Synergistic Combination Therapy for Glioblastoma;Nanomaterials;2023-01-19